×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Contexte :

 

Après plusieurs décennies sans avancées majeures, de nouvelles molécules viennent redéfinir la prise en charge des cancers de l’endomètre.

 

Deux experts vous partagent leur analyse des données actuelles et des dernières recommandations à travers des cas cliniques.

 

Experts :

 

Pr Jean-Sébastien Frenel - Oncologue médical, Institut de Cancérologie de l’Ouest, Saint-Herblain

Pr Isabelle Ray-Coquard - Oncologue médical, Centre Léon Bérard, Lyon

 

Programme :

 

- Présentation des recommandations de Saint Paul de Vence 2025 dans les cancers de l’endomètre avancé ou en rechute

Jean Sébastien Frenel

 

- Cas clinique 1 : Prise en charge des tumeurs dMMR

Isabelle Ray-Coquard

 

- Cas clinique 2 : Prise en charge des tumeurs pMMR

Jean Sébastien Frenel

 

- Débat/Discussion & Réponses aux questions

 

Shooting date : 2025-06-11
Last update : 2025-08-18
Jean-Sébastien Frenel
Saint-Herblain, France
Oncology

Suggestions

Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

Prise en charge des cancers de l'ovaire en rechute :

état des lieux et perspectives

Share
Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, October 18th 2022 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, October 18th 2022 from 09am to 10:30am (GMT+2)
New York : Tuesday, October 18th 2022 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, October 18th 2022 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, October 18th 2022 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, October 18th 2022 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, October 18th 2022 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, October 18th 2022 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, October 18th 2022 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, October 19th 2022 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, October 19th 2022 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, October 19th 2022 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, October 19th 2022 from 05am to 06:30am (GMT+2)

Evolution de la chirurgie du cancer de l’ovaire en 2022

Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT+1)
San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT+1)
New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT+1)
Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT+1)
London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT+1)
Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+1)
Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+1)
Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+1)

Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

éclairages du congrès de la SGO

Share
Scroll Up